Diffusion-weighted magnetic resonance imaging combined with neutrophil-to-lymphocyte ratio predicts pathological response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
Abstract
Diffusion-weighted magnetic resonance imaging combined with neutrophil-to-lymphocyte ratio predicts pathological response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
Fields of Study & Subjects
MRI in cancer diagnosis
Inflammatory Biomarkers in Disease Prognosis
Esophageal Cancer Research and Treatment
Publication details
- Journal / source
- AME Medical Journal
- Volume
- 11
- Pages
- 14–14
- Publication date
- 11 March 2026
- Language
- EN